Aiming to maintain a growth rate of around 18-22 per cent, FMCG firm GlaxoSmithKline will this year introduce around 10-12 products, including some from the international portfolio of its parent company.     

"We want to create a balanced product portfolio and for that the company is constantly expanding its offering. In the current year, we may introduce around 10-12 more products in India," GlaxoSmithKline Consumer Healthcare Executive Vice- President (Marketing) Shubhajit Sen told PTI.     

Also Read   Related Stories News Now - Horlicks aims Rs 50 cr sales from biscuits segment - Red flag for the runs - Dr Reddy's takes an earnings hit, terms it as a one-off event - GSK Consumer to focus on health food drinks - Cavin Kare eyeing more overseas markets - Denial of patent to Gilead beneficial for Indian firms

Also Read   Related Stories News Now - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report More

On the launches from the GSK international's product portfolio, Sen said the company is currently test marketing a new product Breath Easy in India.     

He said, "We have started carrying out test marketing for the product in South and hopefully we will be launching it this year."     

The company had a sales of Rs 1,592 crore last year, of which around Rs 1,200 crore came from Horlicks.     

Sen said the company is working on enhancing the nutrient level of its existing products besides focusing on penetrating deeper into the market.     

"Our focus for this year will be on the health category. We are planning to increase the micronutrient elements of our existing products besides introducing some new categories," he said.

Sen said the company is focusing on increasing presence in the rural markets, which contribute around 30-35 per cent of the overall turnover.     

"We will keep increasing penetration across the country. Though south and east Indian markets have been doing well, we still feel there's lot of scope for growth in the smaller towns there," he said.      

He, however, did not reveal how much the company is planning to spend on various activities lined up this year but said the company earmarks around 12-13 per cent of its sales on marketing and promotional campaigns.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report

Tags : GlaxoSmithKline | FMCG industry | Horlicks | Consumer healthcare   Read Business news in  Advertisements -  Journey on, We are by Your Side. Click here to know more -  2 Lac Apartments, 1 Lac House / Plots. Click here -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  The Best Seller is Also the No. 1 in Mileage. Click here -  Watch The Film Here. Click here to know more.. -  Leader in Passenger Car & Automobile Tyres. Click here -  1 billion in saving for Unilever without any tangles. -  A Brand New Server at a Price That Fits Your Budget. Click here -  Learn How One City is Running on FOOD SCRAPS. -  One Partnership Endless Possibilities. Click here to know more -  Helping doctors detect diseases earlier, saving costs & extending lives. -  36 Lakhs can get you a pool of Luxuries. Click here -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More